The brand-name drugs covered under Medicare Part D have nearly doubled in price, and 25 of them are now up 98% since they debuted in the market, a new AARP Public Policy Institute analysis has found.

Most Sacramento Medicare enrollees are on track to miss serious new savings in 2026, even as federal rule changes cut drug ...

Forbes contributors publish independent expert analyses and insights. Diane Omdahl is a Medicare expert who keeps her readers in the know. If you're on a Part D drug plan, what pharmacy you go do can ...

Drug pricing 2026 forces are reshaping pharmacy economics through Medicare negotiations, FTC actions, and federal pricing ...

Medicare open enrollment, which lasts until Dec. 7, provides beneficiaries the opportunity to evaluate their health care spending, including prescription costs, for 2026. Certain changes, including a ...

Medicare's drug coverage has been dramatically changed for 2025. Figuring out what you should do is one of the most complex challenges you will face in the next few weeks. Only one thing is for sure: ...

Forbes contributors publish independent expert analyses and insights. Diane Omdahl is a Medicare expert who keeps her readers in the know. Last year, Medicare took a baby step toward that goal by ...

Starting Jan. 1, 2025, millions of Americans who get their prescription drugs through Medicare could get a major financial break when a $2,000 out-of-pocket spending cap on medications goes into ...

Specialty medications are driving up dermatology drug spending, with an annual increase of 29.3% from 2013 to 2022. Prescription growth, not price increases, is the primary driver of increased ...